Estracyt

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1988
1988
Plasma and tumour concentrations of estramustine, estromustine, estradiol and estrone, the major metabolites of estramustine… (More)
Is this relevant?
1987
1987
Eighty-two patients with invasive malignant melanoma and no distant metastases were prospectively randomized following their… (More)
Is this relevant?
1985
1985
Ninety-five patients with prostatic carcinoma, stages A-D and of all histological grades were randomized between a continuous and… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
1984
1984
The pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and oral… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1981
1981
Plasma samples from patients with prostatic cancer under oral treatment with estramustine phosphate (Estracyt®) were… (More)
  • figure I
  • table I
  • table III
  • figure 2
Is this relevant?
1980
1980
A preliminary report is presented of prospective, randomized study with continuous and intermittent oral Estracyt treatment in… (More)
Is this relevant?
1980
1980
Two hundred and twelve patients treated for prostatic cancer grade I or II were investigated for cardiovascular complications… (More)
Is this relevant?
1977
1977
Two types of experiments were performed to elucidate the estrogenic effect of estracyt on the ventral and immature rats that had… (More)
Is this relevant?
1976
1976
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in… (More)
Is this relevant?
1974
1974
Hormonal treatment of prostatic carcinoma may give rise to secondary hormone resistance that poses serious problems. Estramustine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?